Evidence map›Paper›PMID 39252948›Full record

ArticleFrontiers in oncology2024

Case report: Surgical treatment and literature review of a recurrent case of glucagonoma.

Zhipeng Liu, Faji Yang, Yijie Hao, Qirong Jiang, Yisu Zhang, Qixuan Zheng, Yupeng Jiang, Jun Lu, Hengjun Gao

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhipeng Liu *Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Faji Yang *Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Yijie HaoDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Qirong JiangDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Yisu ZhangDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, Jinan, China.
Qixuan ZhengDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, Jinan, China.
Yupeng JiangDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Jun LuDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Hengjun GaoDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 40-year-old male patient was admitted due to abdominal distension and discomfort in the upper abdomen persisting for three days. Enhanced CT of the upper abdomen revealed an irregularly dense soft tissue area in the body and tail of the pancreas, approximately 7.6 × 3.1 cm in size, with blurred boundaries, and indistinct separation from the splenic artery and vein. Multiple liver lesions of varying sizes and slightly lower densities were also observed. Liver tumor biopsy considering a neuroendocrine tumor G2, combined with the medical history, led to a diagnosis of pancreatic neuroendocrine tumor G2 with liver metastasis. Physical examination showed mild tenderness in the upper abdomen but no other significant positive signs. During treatment, the patient developed multiple red papular rashes around the mouth, on both lower limbs, and the perineum, accompanied by itching. The glucagon level was 1138.3 pg/L. The patient underwent resection of the pancreatic body and tail, splenectomy, partial liver tumor resection, and cholecystectomy. Within five days post-surgery, the skin lesions began to crust and flake off. On the 14th day post-surgery, the serum glucagon level was rechecked at 136.4 pg/L. As of April 2024, progression of liver lesions was noted, with no significant skin symptoms during the period.

Indexed as

glucagonomaliver metastasis 2pancreatic neuroendocrine tumorrare diseasessurgery

Identifiers

PMID39252948
PMCPMC11381282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.